semaglutide stop production FDA crackdown on off-brand Ozempic products set to take effect, threatening supply Patients Are Left With Few

The first GLP-1 lawsuit was filed in August 2023

Accessed 1/8/2024, AHA

Despite all the changes, it seems likely that compounding pharmacies will continue to offer GLP-1 drugs, at least for the foreseeable future, says Brunner: Some patients will be able to maintain these therapies at a price point they can afford in a customized formulation. The Takeaway The FDA ordered compounding pharmacies to stop producing and selling copies of GLP-1 injectable drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, as official shortages have ended

The injection is placed just under the skin, often in the stomach or upper arm

I am very pleased with her professionalism, knowledge, and non

Wegovy EPAR Product Information (semaglutide 2.4 mg)